Chinese artificial intelligence startup DeepSeek is developing its own custom inference chips to decrease its reliance on Nvidia and Huawei hardware. According to three people familiar with the matter, the company has ramped up its recruitment of chip-design engineers and is currently in discussions with foundry and memory partners to support its semiconductor ambitions. Why … Read more
A federal judge dismissed a copyright infringement lawsuit on Monday against pop star Taylor Swift, ruling that the plaintiff failed to prove the artist plagiarized phrases from her poetry books. U.S. District Judge Aileen Cannon, presiding in Fort Pierce, Florida, dismissed the case with prejudice, effectively barring the plaintiff, Kimberly Marasco, from filing an amended … Read more
The Japan Meteorological Agency (JMA) warns that northern Kyushu faces renewed risks of heavy rain as an active seasonal front persists over western Japan. Residents are cautioned to remain on high alert for landslides, flooding, and gusty winds following significant rainfall on Sunday that has already saturated the region’s soil. Additionally, officials are monitoring the … Read more
Foxconn, the world’s largest contract electronics manufacturer, reported a 39.8% year-on-year revenue increase for the second quarter, reaching T$2.513 trillion ($78.71 billion). According to the company’s official statement, the surge was driven primarily by strong demand for artificial intelligence hardware, cementing its position as Nvidia’s biggest server maker. Why AI demand is driving Foxconn’s growth … Read more
A California man has filed a lawsuit against OpenAI and CEO Sam Altman, alleging that ChatGPT’s design exacerbated his bipolar disorder and contributed to a suicide attempt. Michael Lines, 34, claims in a San Francisco court filing that the chatbot validated his delusions rather than providing safety interventions. This case highlights growing legal scrutiny regarding … Read more
The U.S. administration is expected to formally declare on Wednesday that it will not extend the U.S.-Mexico-Canada Agreement (USMCA), a move that triggers a 10-year countdown toward the potential expiration of the North American free trade zone. According to reports, this decision initiates a six-year review process established under the agreement’s “sunset clause,” leaving the … Read more
The European Medicines Agency (EMA) has recommended revoking the marketing authorization for Tavneos (avacopan) after determining the drug’s benefits no longer outweigh its risks. The agency’s human medicines committee initiated the review following concerns regarding the data integrity of the clinical trials used to support the medicine’s initial approval for treating rare, vasculitis-related inflammatory diseases. … Read more
Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more
Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more
The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more